spectrum pharmaceuticals News
Most Popular spectrum pharmaceuticals Story
Allergan, Specturm ink $345.5M deal
Allergan and Spectrum Pharmaceuticals have signed a development and commercialization deal for apaziquone, an antineoplastic agent in Phase III testing for the treatment of non-muscle invasive... Read more...
Latest Headlines
- October 30, 2008
- February 13, 2008
- July 25, 2007
- July 23, 2007
- October 2, 2006
- September 24, 2006
- June 5, 2006
- March 29, 2006
- March 19, 2006
- March 1, 2006
- January 22, 2006
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
